DaVita (DVA) vs Ensign Group (ENSG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
DaVita (DVA) has outperformed Ensign Group (ENSG) over the past year, gaining 34.9% versus a loss of 2.8%. Over five years, ENSG leads with a +135.4% price change compared with +57.5% for DVA. DaVita is the larger company by market cap ($11.29 billion vs $9.99 billion), about 1.1 times the size, while Ensign Group is growing revenue faster (+18.7% vs +6.5%).
On valuation, DaVita trades at a lower forward P/E (10.3x vs 20.0x for Ensign Group). Ensign Group pays a dividend yielding 0.15%, while DaVita does not currently pay one. Ensign Group converts more of its revenue into profit, with a net margin of 6.8% versus 5.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DVA | ENSG |
|---|---|---|
| Share price | $177.02 | $171.49 |
| Market cap | $11.29B | $9.99B |
| 1-day change | +0.14% | +1.34% |
| YTD return | +55.60% | -1.56% |
| 1-year return | +34.91% | -2.76% |
| 5-year return | +57.54% | +135.43% |
| P/E ratio (TTM) | 14.95 | 26.88 |
| Forward P/E | 10.33 | 20.04 |
| EPS (TTM) | $11.84 | $6.38 |
| Dividend yield | 0.00% | 0.15% |
| Annual dividend | $0.00 | $0.258 |
| Revenue (latest FY) | $13.64B | $5.06B |
| Revenue growth (YoY) | +6.46% | +18.72% |
| Net income (latest FY) | $746.80M | $343.97M |
| Gross margin | — | 20.54% |
| Operating margin | 14.98% | 8.41% |
| Net margin | 5.47% | 6.80% |
| 52-week high | $247.49 | $218.00 |
| 52-week low | $101.00 | $141.58 |
| Distance from 52-week high | -28.47% | -21.33% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +24.20% | +28.29% |
| Average volume | 769.40K | 375.95K |
| Shares outstanding | 63.80M | 58.28M |
| Employees | 78,000 | 46,000 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Hospital/Nursing Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DVA has outperformed ENSG by 37.7 percentage points over the past year.
- Ensign Group trades at a higher earnings multiple (26.9x vs 15.0x trailing P/E).
- Ensign Group grew revenue faster in its latest fiscal year (+18.72% vs +6.46%).
About DaVita
DVA stock →DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
Health Care · Misc Health and Biotechnology Services · 78,000 employees
About Ensign Group
ENSG stock →The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services.
Health Care · Hospital/Nursing Management · 46,000 employees
DVA vs ENSG FAQ
Which is bigger, DaVita or Ensign Group?
DaVita (DVA) is larger, with a market capitalization of $11.29B compared with $9.99B for Ensign Group (ENSG).
Which stock has performed better over the past year, DVA or ENSG?
DVA returned +34.91% over the past 12 months, compared with -2.76% for ENSG (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, DVA or ENSG?
DVA has the lower trailing P/E at 15.0, versus 26.9 for ENSG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, DaVita or Ensign Group?
Ensign Group pays a dividend yielding 0.15%, while DaVita does not currently pay a regular dividend.
Are DaVita and Ensign Group in the same industry?
Both are in the Health Care sector, but in different industries: Misc Health and Biotechnology Services for DaVita and Hospital/Nursing Management for Ensign Group.